Skip to content

An exploratory study to investigate the effect of FE 999302 when given together with follitropin delta during controlled ovarian stimulation

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-507630-25-00
Acronym
000426
Enrollment
600
Registered
2024-05-22
Start date
2024-06-14
Completion date
2025-09-05
Last updated
2025-07-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility in women undergoing assisted reproductive technologies (ART)

Interventions

None listed

Sponsors

Ferring Pharmaceuticals A/S
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Belgium, Czechia, Denmark, Norway, Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026